Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (81-90 of 405) with videos related to

Pageof 41
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2016
PD-L1 Expression in Lung CancerHui Yu, Theresa A Boyle, Caicun Zhou, et al.
The Journal of International Medical Research|December 28, 2019
Treatment of spine metastases in cancer: a reviewYu Chen, Yayi He, Chao Zhao, et al.
Seminars in Oncology|March 15, 2002
HER2/neu expression in malignant lung tumorsFred R Hirsch, Wilbur A Franklin, Robert Veve, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseasesDavid H Garfield, Jacques L Cadranel, Marie Wislez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selectionAntonio Jimeno, Wells A Messersmith, Fred R Hirsch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008
The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature reviewFred R Hirsch, Anna Spreafico, Silvia Novello, et al.
Cancer Journal (Sudbury, Mass.)|April 25, 2009
KRAS mutations and susceptibility to cetuximab and panitumumab in colorectal cancerAntonio Jimeno, Wells A Messersmith, Fred R Hirsch, et al.
Seminars in Oncology|March 15, 2002
Epidermal growth factor receptor family in lung cancer and premalignancyWilbur A Franklin, Robert Veve, Fred R Hirsch, et al.
Cancer Treatment Reviews|December 8, 2023
The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancerFortunato Ciardiello, Fred R Hirsch, Robert Pirker, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Targeted molecular mechanisms of epoetin alfaCorey J Langer, Fred R Hirsch, Hernan Cortés-Funes, et al.
Pageof 41

Showing results (81-90 of 405) with videos related to

Sort By:
Pageof 41
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2016
PD-L1 Expression in Lung CancerHui Yu, Theresa A Boyle, Caicun Zhou, et al.
The Journal of International Medical Research|December 28, 2019
Treatment of spine metastases in cancer: a reviewYu Chen, Yayi He, Chao Zhao, et al.
Seminars in Oncology|March 15, 2002
HER2/neu expression in malignant lung tumorsFred R Hirsch, Wilbur A Franklin, Robert Veve, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseasesDavid H Garfield, Jacques L Cadranel, Marie Wislez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selectionAntonio Jimeno, Wells A Messersmith, Fred R Hirsch, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2008
The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature reviewFred R Hirsch, Anna Spreafico, Silvia Novello, et al.
Cancer Journal (Sudbury, Mass.)|April 25, 2009
KRAS mutations and susceptibility to cetuximab and panitumumab in colorectal cancerAntonio Jimeno, Wells A Messersmith, Fred R Hirsch, et al.
Seminars in Oncology|March 15, 2002
Epidermal growth factor receptor family in lung cancer and premalignancyWilbur A Franklin, Robert Veve, Fred R Hirsch, et al.
Cancer Treatment Reviews|December 8, 2023
The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancerFortunato Ciardiello, Fred R Hirsch, Robert Pirker, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Targeted molecular mechanisms of epoetin alfaCorey J Langer, Fred R Hirsch, Hernan Cortés-Funes, et al.
Pageof 41